DeepMed Research

Microcrystalline cellulose

Generic Name: Microcrystalline cellulose

Drug Type: Small Molecule

CAS Number: 9004-34-6

Unique Ingredient Identifier: BX81F82EWG

Background: A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.

Indication: 用于体表创伤、外科创面止血及上消化道出血。

Associated Conditions: Vaginal burning sensation, Vaginal itching

Clinical Trials

Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia

Phase 4

Terminated

Conditions: Hyperkalemia

Interventions: Drug: Silicified microcrystalline cellulose
Drug: Sodium polystyrene sulfonate

First Posted Date: 2013-05-31

Last Posted Date: 2014-09-03

Lead Sponsor: ZS Pharma, Inc.

Target Recruit Count: 32

Registration Number: NCT01866709

Locations: 🇺🇸
Riverside Clinical Research, Edgewater, Florida, United States

Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis

Phase 2

Completed

Conditions: Gastroenteritis

Interventions: Drug: micro-crystalline cellulose
Drug: LGG

First Posted Date: 2013-01-23

Last Posted Date: 2019-09-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 971

Registration Number: NCT01773967

Locations: 🇺🇸
St. Louis Children's Hospital, Saint Louis, Missouri, United States
🇺🇸
Children's Hospital of New York, New York, New York, United States
🇺🇸
UC Davis Medical Center, Sacramento, California, United States

and more 7 locations

Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow Trauma

Not Applicable

Conditions: Elbow Trauma Requiring Operative Management

Interventions: Drug: Indomethacin and Pantoprazole
Drug: microcrystalline cellulose powder tablets

First Posted Date: 2012-12-06

Last Posted Date: 2017-03-23

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 150

Registration Number: NCT01744314

Locations: 🇨🇦
HULC, St Joseph's Health Care, London, Ontario, Canada

Treatment of Low Metabolic Rate Following Bariatric Surgery

Not Applicable

Completed

Conditions: Morbid Obesity

Interventions: Drug: Ephedrine sulfate with caffeine
Drug: cellulose

First Posted Date: 2012-05-11

Last Posted Date: 2015-09-24

Lead Sponsor: Oregon Weight Loss Surgery, LLC

Target Recruit Count: 218

Registration Number: NCT01596907

Locations: 🇺🇸
Oregon Weight Loss Surgery, LLC, Beaverton, Oregon, United States
🇺🇸
Oregon Weight Loss Surgery, Portland, Oregon, United States

Study of SI000413 in Knee Osteoarthritis Patients

Phase 2

Conditions: Osteoarthritis, Knee

Interventions: Drug: SI000413
Drug: microcrystalline cellulose

First Posted Date: 2012-02-03

Last Posted Date: 2013-08-13

Lead Sponsor: Dong-A Pharmaceutical Co., Ltd.

Target Recruit Count: 152

Registration Number: NCT01525758

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Yongon-dong, Chongno-gu, Korea, Republic of
🇰🇷
KyungHee University medical center, Seoul, Hoegi-dong, Dongdaemun-gu, Korea, Republic of
🇰🇷
Ajou University Medical Center, Gyeonggi-do, Woncheon-dong Yeongtong-gu, Suwon, Korea, Republic of

Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

Phase 1

Completed

Conditions: Depression

Interventions: Drug: NSI-189 Phosphate
Drug: microcrystalline cellulose capsules

First Posted Date: 2012-01-30

Last Posted Date: 2014-04-02

Lead Sponsor: Neuralstem Inc.

Target Recruit Count: 26

Registration Number: NCT01520649

Locations: 🇺🇸
California Clinical Trials, Glendale, California, United States

Pharmacological Treatment In Osteoarthritis

Phase 3

Completed

Conditions: Osteoarthritis

Interventions: Drug: Hydroxychloroquine
Drug: cellulose

First Posted Date: 2010-06-22

Last Posted Date: 2015-04-13

Lead Sponsor: Maasstad Hospital

Target Recruit Count: 200

Registration Number: NCT01148043

Locations: 🇳🇱
Sint Franciscus Gasthuis, Rotterdam, Netherlands
🇳🇱
Vlietland Hospital, Schiedam, Netherlands
🇳🇱
ZorgSaam Zeeuws-Vlaanderen, Terneuzen, Netherlands

and more 3 locations

Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Purified isoflavones
Drug: Methyl cellulose blend

First Posted Date: 2009-12-21

Last Posted Date: 2019-08-06

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 71

Registration Number: NCT01036321

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
🇺🇸
University of Florida & Shands Medical Center - Jacksonville, Jacksonville, Florida, United States
🇺🇸
James A. Haley VA Hospital, Tampa, Florida, United States

Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel Syndrome

Phase 4

Conditions: Irritable Bowel Syndrome

Interventions: Drug: Methyl cellulose powder (low viscosity)
Drug: Saccharomyces boulardii

First Posted Date: 2007-10-15

Last Posted Date: 2007-10-15

Lead Sponsor: Aga Khan University

Target Recruit Count: 42

Registration Number: NCT00543478

Locations: 🇵🇰
Gastroenterology outpatients clinics,Aga Khan University hospital, Karachi., Pakistan

Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects

Phase 2

Conditions: Osteoarthritis, Knee
Osteoarthritis, Hip

Interventions: Drug: CG100649
Drug: Silicified microcrystalline cellulose + talc

First Posted Date: 2007-09-17

Last Posted Date: 2008-06-13

Lead Sponsor: CrystalGenomics, Inc.

Target Recruit Count: 240

Registration Number: NCT00530452

Locations: 🇩🇪
Orthopaedische Praxis, Bad Dürrheim, Baden-Württemberg, Germany

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy